OSE Immunotherapeutics SA/€OSE

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About OSE Immunotherapeutics SA

OSE Immunotherapeutics SA is a biotechnology company focused on the research and development of immunotherapies in the fields of immune-oncology, autoimmune diseases, and transplantation. The company aims to innovate through its pipeline, which includes products such as Tedopi, a therapeutic vaccine for non-small cell lung cancer, and CoVepiT, a COVID-19 vaccine. Founded in 2012 and headquartered in Nantes, France, OSE Immunotherapeutics combines strong scientific expertise with a strategic emphasis on building a diversified portfolio of advanced clinical trials. The company's competitive strength lies in its proprietary technologies and strategic partnerships, enhancing its capabilities to address significant unmet medical needs globally.

Ticker

€OSE

Primary listing

PAR

Industry

Biotechnology
Headquarters

Employees

64

OSE Metrics

BasicAdvanced
€154M
4.56
€1.48
0.58
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €OSE

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs